Correction: Seroprevalence of SARS-CoV-2 virus antibodies and sociodemographic features of pregnant women in Mogadishu, Somalia: a cross-sectional survey study

Correction: Seroprevalence of SARS-CoV-2 virus antibodies and sociodemographic features of pregnant women in Mogadishu, Somalia: a cross-sectional survey study

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-06-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/12/6/e059617corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Seroprevalence of SARS-CoV-2 virus antibodies and sociodemographic features of pregnant women in Mogadishu, Somalia: a cross-sectional survey study
by: Maryan Abdullahi Sh. Nur, et al.
Published: (2022-06-01)

Effects of office hours on the academic performance of students in Mogadishu universities, Somalia
by: Ahmed Absuge Gabow, et al.
Published: (2025-12-01)

Exploring the effect of financial technology on the sustainability of small and medium enterprises in Mogadishu, Somalia
by: Mohamed Abdi Elmi, et al.
Published: (2025-12-01)

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022.
by: Anna Bratcher, et al.
Published: (2025-01-01)

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022
by: Anna Bratcher, et al.
Published: (2025-01-01)

Prevalence of depression and its correlates among undergraduate health science students in Mogadishu, Somalia: a cross-sectional study
by: Bashiru Garba, et al.
Published: (2025-02-01)

Lymphadenopathies: A Retrospective Study of Epidemiology, Characteristics, Diagnosis and Treatment Outcomes of Patients in a Tertiary Hospital in Mogadishu-Somalia
by: Kıratlı K, et al.
Published: (2025-01-01)

Seroprevalence of SARS-CoV-2 Infection Among People Living with HIV in Libreville, Gabon
by: Samira Zoa-Assoumou, et al.
Published: (2024-12-01)

Seroprevalence of SARS-CoV-2 in Children Admitted to a Pediatric Ward of an Urban Hospital
by: Rama Kaja, et al.
Published: (2022-12-01)

Etiology, Clinical Manifestations, and Imaging Evaluation of Intestinal Obstruction in Adults at Tertiary Hospital in Mogadishu, Somalia: A Retrospective Study [Letter]
by: Indiran V
Published: (2025-01-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

Investigating SARS-CoV-2 Neutralising Antibody Response in Sheep
by: Milena Samojlović, et al.
Published: (2024-12-01)

Study of Radioclinical and Risk Factors of Cerebral Venous Thrombosis: A Retrospective Analysis of Patients Presenting to a Tertiary Hospital in Mogadishu, Somalia
by: Adam BA, et al.
Published: (2025-01-01)

Ebola Virus and SARS-CoV-2: Similarities and Differences
by: Robert C. SIZEMORE, et al.
Published: (2020-07-01)

SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021
by: Ulla Ashorn, et al.
Published: (2022-06-01)

The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting.
by: Ching-Wen Hou, et al.
Published: (2025-01-01)

Correction: SARS-CoV-2 vaccines in patients with SLE
Published: (2021-04-01)

Correction: IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi.
by: Muhammad Hasan, et al.
Published: (2024-01-01)

Environmental biocontamination by SARS-CoV-2 Virus in the hospital setting
by: M Espejo Mambié, et al.
Published: (2025-01-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

Neutralizing antibodies against SARS-CoV-2 of vaccinated healthcare workers in Taiwan
by: Seto Priyambodo, et al.
Published: (2025-12-01)

Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study.
by: Irene Bagala, et al.
Published: (2024-01-01)

Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors
by: May Raouf, et al.
Published: (2021-07-01)

Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study
by: Irene Bagala, et al.
Published: (2024-01-01)

Fetal Deaths in SARS-CoV-2-Infected Pregnant Women: A Portuguese Case Series
by: Ana Rita Mira, et al.
Published: (2022-01-01)

Evaluation of hearing screening results of newborns born to SARS-CoV-2 positive pregnant women
by: Ünal Akça, et al.
Published: (2025-01-01)

Ready-To-Use Microwave Sensor Modified by Antibody-AuNPs Nanoconjugate for Highly Sensitive and Selective Detection of the SARS-CoV‑2 Virus
by: Jin Wang, et al.
Published: (2024-10-01)

Development of the test kit for detection of SARS-CoV-2 antibodies in sera of susceptible animals
by: M. A. Volkova, et al.
Published: (2021-07-01)

Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico
by: Zachary J. Madewell, et al.
Published: (2024-12-01)

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
by: Radi Taha Alsafi
Published: (2022-01-01)

Seroprevalence, Associated Factors, and Fetomaternal Outcome in Pregnant Women That Tested Positive to Hepatitis E Antibodies in Nigeria
by: Valentine Chimezie Okwara, et al.
Published: (2021-01-01)

The Myth of Air Purifier in Mitigating the Transmission Risk of SARS-CoV-2 Virus
by: Lip Huat Saw, et al.
Published: (2022-01-01)

Clinical Evaluation of Acute Pancreatitis Caused by SARS-CoV-2 Virus Infection
by: Hulya Vatansev, et al.
Published: (2021-01-01)

Editorial: Impact of the SARS-CoV-2 pandemic on the evolution and epidemiology of other viruses
by: Alfonso J. Rodríguez-Morales, et al.
Published: (2024-12-01)

Author Correction: Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
by: Pablo N. Perez-Guzman, et al.
Published: (2023-12-01)

Author Correction: Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza
by: Istvan Bartha, et al.
Published: (2025-01-01)

Direct detection of 4-dimensions of SARS-CoV-2: infection (vRNA), infectivity (antigen), binding antibody, and functional neutralizing antibody in saliva
by: Aida Mohammadi, et al.
Published: (2024-12-01)

Transitory Fetal Skin Edema in a Pregnant Patient with a Mild SARS-CoV-2 Infection
by: Alicia Martínez-Varea, et al.
Published: (2021-01-01)

Seroprevalence of IgM/IgG and Neutralizing Antibodies against SARS-CoV-2 in Unvaccinated Young Adults from Mexico Who Reported Not Having Had a Previous COVID-19 Infection
by: Diana Lourdes Padilla-Bórquez, et al.
Published: (2024-01-01)

Diagnostic Performance of Three ELISAs for Detection of Antibodies against SARS-CoV-2 in Human Samples
by: Cássio Meira, et al.
Published: (2022-01-01)